ArticleMolecular cancer therapeutics2026

In Vivo Auto-tuning of Antibody-Drug Conjugate Delivery to Maximize Efficacy Using High-Avidity, Low-Affinity Antibodies.

Anna Kopp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.